AI-Powered Weapons Startup Raises $1.5B & Mou...

Up next

Apple Enters the Smart Home Market & Does OpenAI Have a Spy Problem?

#954: Apple unveils its newest foray into the smart home market with ‘HomeView,’ which looks like a giant Apple Watch. Bumble agrees to go private for $1.3B Character.ai files for Chapter 11 bankruptcy. An OpenAI employee is arrested by the FBI for planting a recording device in ... Show more

. 30min 55sec

Trump Strikes Controversial Oil Deal With Russia & Low Payroll MLB Teams Dominate Postseason

#953: Trump faces backlash after securing a deal with Russia for diesel fuel. Pepsi is feeling the hurt as the GLP-1 movement is causing shoppers to cut back on sodas and snacks. Two American economists win the Nobel Prize for their work on managing economic shocks. 3 out of the ... Show more

. 32min 9sec

Recommended Episodes

Pfizer’s Second Gut Punch Shows Pitfalls of Weight-Loss Pills

Bloomberg Businessweek

Bloomberg News Health Reporter Madison Muller explains how Pfizer’s second weight-loss setback this year is a warning sign that breaking into the lucrative obesity market isn’t going to be easy. Cory Klippsten, CEO at Swan Bitcoin, shares his crypto outlook for 2024. Benjamin Wo ... Show more

. 42min 33sec

Obesity Drugs Enjoy a Much-Needed Winning Streak

Bloomberg Businessweek

Bloomberg Opinion Pharma Columnist Lisa Jarvis and Bloomberg News Health Reporter Madison Muller discuss a how a clinical trial in obesity drugs is punctuating a string of positive developments that could make the treatments more widely accessible. Kate Hao, Founder and CEO of Ha ... Show more

. 41min 10sec

Congress in Chaos, The Ozempic Effect, and the Healthcare Strike

Pivot

Kara and Scott discuss declining social media traffic to news sites, Amazon using an algorithm to test how high they could boost prices, and why the boom in weight loss drugs is the “biggest business story of the year.” Also, Kevin McCarthy’s historic ouster marks another predict ... Show more

. 1h 4min

Pfizer plays hardball in weight-loss drug fight

FT News Briefing

Palantir lifted its 2025 revenue guidance and Pfizer has filed a second lawsuit against Novo Nordisk and obesity drug start-up Metsera. Plus, OpenAI inked a $38bn computing deal with Amazon, and the FT’s Claire Jones explains how the Trump administration is considering pushing fo ... Show more

. 11min 3sec